Thierry Sornasse has over 25 years of experience in the biotechnology and pharmaceutical industry with advanced expertise in translational science across multiple indications including rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), systemic lupus erythematosus (SLE), primary Sjogren’s syndrome (pSS), giant cell arteritis (GCA), systemic sclerosis, (SSc), and idiopathic pulmonary fibrosis (IPF).
Thierry obtained his PhD at the “Université Libre de Bruxelles” in Belgium, where he studied the role of dendritic cells in the regulation of the immune response and completed a postdoctoral fellowship at DNAX Research Institute where he studied mechanisms for induction of human T helper cell differentiation.
San Francisco, CA, USA
Senior Scientific Director, Precision Medicine Immunology